P260 Disease duration in Crohn’s disease is a strong determinant for having a colectomy in geriatric population
H. Htet*1, T. Mudege1, S. Hoque1
1Whipps Cross Hospital, Barts Health NHS Trust, London, UK
Geriatric population is swiftly growing in most developed countries. Looking after inflammatory bowel disease (IBD) in elderly population has become a clinical challenge due to their co-morbidities, frailty, polypharmacy with multiple drug interactions. In our study, we evaluate the clinical course, treatment, and outcome in our geriatric IBD population in a large district general hospital.
We identified an IBD geriatric group with age 65 and above from our existing database from 2014 onward. Data were extracted from electronic database. Extracted data included gender, age of diagnosis, duration of disease, disease characteristics using Montreal classification, and surgical outcomes. χ2-test was performed on non-parametric data using R studio program.
Since 2014, we identified 105 IBD patients with age above 65 years. Forty-one out 105 (39%) have Crohn’s disease. Sex ratio is equally distributed (M:F= 21:20).
Boxplot of age, age of diagnosis, and disease duration.
Age ranges from 65 to 90 with median age of 71. Age of diagnosis ranges from 23 to 82 with median age of 59. Disease duration ranges from 0 to 58 years with a median age of 14.
Of 41, 12 (29%) had colectomies and 8 (67%) has L1 disease and 4 (33%) had L3 disease.
Colectomy is associated with disease duration of more than 10 years (29% vs. 0%, χ2 = 5.94,
In our cohort of Crohn’s disease, patients aged above 65 years, regardless of the age of disease onset, longer disease duration is associated with colectomies mainly in L1 and L3 disease.